Stay updated on Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe site revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Show glossary and Hide glossary controls and updated QC-related display items to show Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing the older labels/versions.SummaryDifference0.3%

- Check60 days agoChange DetectedThe page shows a new revision tag: v3.3.4, replacing the previous v3.3.3. This indicates a small update to the page's metadata without changing the study content.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page now includes a 'Locations' section with Georgia as a listed study location, and the previous 'Georgia Locations' entry was removed; the 'HHS Vulnerability Disclosure' footer link was also removed.SummaryDifference0.2%

Stay in the know with updates to Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page.